On Demand 2016 Allied Health Professionals Course and Concurrent Workshops

Price: $144 members, $216 non-members

You can earn up to 11.25 AMA PRA Category 1 Credit(s)™

This package is a collection of Allied Health Professionals Course and Workshops.

  • Allied Health Professionals Course General Session
  • AHP1 Increasing Your Competence in Special Testing Procedures and Office Therapeutics 
  • AHP2 Nuts and Bolts of Spirometry Interpretation 
  • AHP4 Interesting Dermatological Cases in Allergy Practice 

Release Date: 12/01/2016
Expiration Date: 11/30/2019


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 11.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

  • Describe the link between obesity and asthma; develop tools to provide patient education regarding that link; and identify appropriate referrals for the obese asthmatic.
  • Identify different phenotypes in asthma; discuss the clinical implications for management related to the various phenotypes; and review novel therapies and future direction of biologicals in the management of asthma among diverse populations.
  • Evaluate the history of stinging insect reaction; review the differences in types of stinging insect categorization; and describe stinging insect evaluation and management.
  • Explore the treatment options for managing allergic rhinitis optimally; develop appropriate patient education for each type of SLIT therapy currently being used; and discuss the use and overuse of antimicrobial therapy in sinusitis.
  • Review the indications for each type of testing procedure or therapeutic; and discuss reactions and/or anaphylaxis management associated with these procedures.
  • Describe when and how to utilize pulmonary function testing in the context of clinical symptoms and diagnoses; apply knowledge of the actual test performance to both the patient and technician when coaching spirometry; and recognize abnormal spirometry measurements and validity of testing.
  • Describe the common comorbid conditions seen in the asthma and allergy office; and educate patients on how to best self-manage these conditions.
  • Discuss a variety of dermatological manifestations seen in allergy practice; differentiate allergic, contact, irritant and other possible etiologies for the myriad complaints of dermatological disease; and discuss management to include the most current topicals utilized for both acute and chronic management.
  • Analyze the variety of coping mechanisms used by children and adults and their families in dealing with chronic allergic illness (allergic rhinitis, asthma, food allergy); describe effective methods to assist individuals and families to develop and support healthy coping strategies; and discuss how anxiety and other psychological adaptation to illness affect adherence to therapy and learning.
  • Describe the approaches to early food introduction for at-risk infants.
  • Compare and contrast the delivery of asthma education using a new needs-based approach to the conventional disease based curriculum: inhaler readiness, managing food allergies and managing asthma and anaphylaxis in the community; and identify strategies that improve schools’ and students’ capability to manage allergic disease.
  • Recognize the signs and symptoms of a patient with immunodeficiency and understand the tools used to diagnose these diseases; and review the management strategy for patients with immunodeficiency.
Additional information

Christine W. Wagner, RN, MSN, CPNP, AE-C -- Consultant/Advisor: Meda, Teva; Speaker: Meda, Teva

Michael Schatz, MD, MS, FACAAI -- Consultant/Advisor: Amgen, Boston Scientific; Supported/Contracted Research: GlaxoSmithKline, MedImmune, Merck

Cheryl K. Bernstein, BSN, RN, CCRC -- Supported/Contracted Research: Amgen, AstraZeneca, Boehringer Ingelheim, CSL Behring, Circassia, Dyax, GlaxoSmithKline, MedImmune, Meda, Merck, Mylan, Novartis, Pfizer, Regeneron, Shire, Stallergenes, Teva

Stanley M. Fineman, MD, MBA, FACAAI -- Consultant/Advisor: Aimmune; Speaker: AstraZeneca, Boehringer Ingelheim, Genentech, Greer, Meda, Novartis, Nestle, Teva; Supported/Contracted Research: DBV Technologies, Genentech, Greer, Meda, Aimmune, Stallergenes

B. Gwen Carlton, DNP, FNP-BC, AE-C -- Speaker: Genentech

Deidra H. Sanders, RN, MSN, APRN, FNP-BC -- Consultant/Advisor: AllergyZone, Meda; Speaker: Meda

Jodi A. Shroba, MSN, APRN, CPNP -- Speaker: Meda

Charlotte M. Jacobsen, MSN, RN -- Consultant/Advisor: CSL Behring, Shire

Maureen George, PhD, RN, AE-C, FAAN -- Consultant/Advisor: Teva; Speaker: Teva

The following have no financial relationship to disclose:

Kimberly G. Clay, MN, APRN, FNP-BC, Moderator

Helen M. Murphy, BHS, RRT, AE-C

Christina E. Ciaccio, MD, FACAAI

Melissa T. Korenblat-Hanin, ACSW-LCSM

Karen L. Gregory, DNP, APRN, CNS, RRT, AE-C, FAARC

Christopher D. Miller, MD

Concettina Tolomeo, DNP, APRN, FNP-BC, AE-C

Theodore M. Freeman, MD, FACAAI

Course summary
Available credit: 
  • 11.25 AMA PRA Category 1 Credit™
  • 11.25 Attendance
  • 11.25 CBRN
Course opens: 
Course expires: 

Available Credit

  • 11.25 AMA PRA Category 1 Credit™
  • 11.25 Attendance
  • 11.25 CBRN


Please login or create an account to take this course.